ClinicalTrials.Veeva

Menu

Exercise During Chemotherapy for Patients With Hematological Malignancies

Charité University Medicine Berlin logo

Charité University Medicine Berlin

Status and phase

Unknown
Phase 3

Conditions

Hematological Malignancies
Hematological Diseases

Treatments

Behavioral: Fatigue counseling
Other: Aerobic exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT00884364
EA4/031/09

Details and patient eligibility

About

The trial will evaluate the effects of aerobic exercise in patients undergoing chemotherapy for the treatment of a hematological neoplastic disease.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hematological malignant disease
  • Current chemotherapy
  • Understanding of written German

Exclusion criteria

  • Cardiorespiratory, metabolical, osteoarticular or immunological disorders which can be aggravated by exercise
  • Pathological stress-ECG at recruitment

Trial design

60 participants in 2 patient groups

Control
Active Comparator group
Treatment:
Behavioral: Fatigue counseling
Exercise
Experimental group
Treatment:
Other: Aerobic exercise

Trial contacts and locations

1

Loading...

Central trial contact

Fernando Dimeo, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems